Neo Ivy Capital Management Ab Cellera Biologics Inc. Transaction History

Neo Ivy Capital Management

  • $294 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023
BUY
$5.66 - $7.59 $139,066 - $186,486
24,570 Added 106.01%
47,748 $308,000
Q4 2022

Mar 24, 2023
BUY
$9.48 - $14.52 $199,326 - $305,297
21,026 Added 977.04%
23,178 $234,000
Q3 2022

Nov 15, 2022
BUY
$9.2 - $13.68 $19,798 - $29,439
2,152 New
2,152 $21,000

Others Institutions Holding ABCL

# of Institutions
154
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Neo Ivy Capital Management Portfolio

Follow Neo Ivy Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email